Oncotarget’s Expanded Subject Matter Reflects Success Within the Scientific Community

Oncotarget is a medical journal which has historically focused on oncology, and all research related to cancer. However, they have recently opened up to include the medical fields of Neuroscience, Cardiology, and Cell Biology, as well as several other medical specialties. The success and positive reception of the journal by the scientific community might be one reason for the expansion.

Oncotarget was first published in 2010. It is a peer-reviewed journal, meaning that each article is reviewed by several scientists, providing a rigorous filter for scientific articles. This fosters community dialogue, scientific accuracy, and the spread of knowledge. Historically the journal has accepted and published articles about the pathology of cancer. The articles relate to how cancer progresses within the body, and different ways to target the disease and treat it with pharmacological means. Research regarding therapeutic agents has been a main point of focus for the published articles in the seven years since the journal first started. Follow Oncotarget on Twitter.

How does a publication such as this one maintain the rigor of its peer review process?

The materials that they publish are often cutting edge research, just introduced to the field. They are dealing with treatment options for cancer patients, and evidence of therapeutic agents success or challenges in treating cancer. These challenging subject matters are put through the peer-review process under the guidance of the principles of COPE. COPE stands for the Committee on Publication Ethics. Oncotarget subscribes to the principles that COPE puts forth, including the standards for the way editors manage the position of leadership within the journal.

COPE sets out a code of conduct which states that all editors should consider seriously the responsibility that they hold within the scientific community. The code of conduct specifically calls editors of medical journals are “guardians of biomedical science” and says that they must make sure that they take steps to make sure that practices within the publishing process are ethical. Oncotarget adheres to these principles. Oncotarget is a valuable member of the scientific community because they help to distribute material in an ethical manor. The expansion of topics that the journal will cover speaks to their success. Visit his profile on Google Scholar.